Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Dr. Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Chinese Academy of Medical Sciences and Peking Union Medical College | China 

Author Profile

Scopus 

Orcid ID

📘 KUANGYU YEN, PhD: PIONEER IN TRANSCRIPTION REGULATION AND CHROMATIN DYNAMICS

🎓 EARLY ACADEMIC PURSUITS

Kuangyu Yen's academic journey began at National Taiwan University, where he earned a Bachelor of Science in Horticulture (Molecular Biology Unit) in 1998. His passion for molecular biology led him to pursue advanced degrees at the University of Manchester, UK, where he completed both an MRes (2001) and a Ph.D. in Molecular Biology (2005). His doctoral research laid the foundation for his expertise in transcription regulation, setting the stage for his future research endeavors.

💼 PROFESSIONAL ENDEAVORS

Dr. Yen's professional career is marked by a blend of international experiences and prestigious appointments:

  • Chinese Academy of Medical Sciences & Peking Union Medical College (2022-present): Researcher.
  • Southern Medical University (2014-2022): Professor, where he contributed significantly to the academic and research community in Guangzhou, China.
  • Pennsylvania State University (2008-2014): Post-doctoral fellow and later Research Assistant Professor, expanding his expertise in transcription regulation and chromatin dynamics.
  • University of Washington (2005-2007): Post-doctoral fellow, further deepening his understanding of molecular biology at the intersection of chromatin and transcription.
  • National Taiwan University (1998-2000): Research Assistant, where his scientific curiosity began to flourish.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATION AND EPIGENETICS

Dr. Yen's research focus is on transcription regulation and its influence on cell fate determination, particularly through chromatin dynamics. His innovative use of bioinformatic tools, CRISPR/Cas9-engineered depletion, and biochemical reconstitution has made him a leader in understanding how chromatin regulates transcription in a spatiotemporal manner. His research has significant implications for disease diagnosis and treatment, especially in preventing precancerous cells from progressing into cancer cells. One of his notable contributions is the development of a two-tipping point model, which helps explain how cell fate transitions. This model has potential applications in both basic research and clinical practice, offering insights into the molecular mechanisms of various diseases.

🌍 IMPACT AND INFLUENCE

Dr. Yen’s work has been internationally recognized, and he has secured multiple high-profile grants and awards, such as the Thousand Youth Talents Award and the Outstanding Youth Award. His research has attracted funding from the National Natural Science Foundation of China, the National Key Research and Development Program of China, and international collaborations such as the France-China Joint Research Projects Program. His influence extends to key speaking engagements and workshops in the field of epigenetics and hematopoiesis at global institutions, including John Hopkins University.

📊 ACADEMIC CITATIONS

With several publications to his name, Dr. Yen’s work is well-cited in the scientific community, reinforcing his status as an influential researcher in molecular biology. His contributions to understanding transcription regulation and chromatin dynamics continue to resonate, particularly in the areas of epigenetics and hematopoiesis.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Kuangyu Yen’s legacy will likely center on his pioneering research into how chromatin structure affects transcriptional regulation and cell fate transitions. His use of cutting-edge tools like CRISPR/Cas9 and bioinformatics has laid the groundwork for future advancements in cancer prevention and molecular diagnostics. Moving forward, Dr. Yen’s ongoing research at the Chinese Academy of Medical Sciences is poised to further influence how scientists understand and manipulate transcription regulation. His editorial role at Communication Biology (2024-2026) and other professional activities suggest that his contributions to the field are far from over.

🚀 AWARDS AND PROFESSIONAL RECOGNITION

  • National Natural Science Foundation of China: Multiple grants for outstanding research, totaling over 500,000 USD.
  • Thousand Youth Talents Award: A prestigious recognition with funding of 0.67 million USD.
  • Numerous invited talks at top-tier institutions and international conferences.

Kuangyu Yen’s continuous dedication to his research and the academic community positions him as a transformative figure in molecular biology, with future contributions set to further shape the field.

📅 FUTURE HIGHLIGHTS

Dr. Yen’s ongoing projects and his active engagement with the scientific community, including participation in international editorial boards and professional panels, indicate that his work will continue to shape the future of molecular biology research for years to come.

📑NOTABLE PUBLICATIONS 

"RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation" 

  • Authors: Liu, S., Yang, J., Sun, G., Yen, K., & Lu, T. (2021).
  • Journal: Molecular Biosciences
  • Year: 2021

"Chemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae" 

  • Authors: Lai, S., Kumari, A., Liu, J., Yen, K., & Xu, J.
  • Journal: Genetics and Genomics
  • Year: 2021

"Comprehensive understanding of Tn5 insertion preference improves transcription regulatory element identification"

  • Authors: Zhang, H., Lu, T., Liu, S., Chen, F., & Yen, K.
  • Journal: NAR Genomics and Bioinformatics
  • Year: 2021

"Functional Verification of Novel ELMO1 Variants by Live Imaging in Zebrafish"

  • Authors: Xue, R., Wang, Y., Wang, T., Liu, Q., & Xu, J.
  • Journal: Frontiers in Cell and Developmental Biology
  • Year: 2021

"SPI1-KLF1/LYL1 axis regulates lineage commitment during endothelial-to-hematopoietic transition from human pluripotent stem cells"

  • Authors: Qu, K., Mo, S., Huang, J., Shen, J., & Yen, K.
  • Journal: iScience
  • Year: 2024

Li Wan | Bipolar Disorder | Best Researcher Award

Prof Li Wan | Bipolar Disorder | Best Researcher Award

Affiliated Psychological Hospital Of Anhui Medical University | China

Author Profile 

Scopus

Orcid ID

Dr. Li Wan: Expert in Cognitive Neuropsychology and Neuromodulation 🧠

Educational Background 🎓

  • Ph.D. in Psychology (2006) - Virginia Polytechnic Institute and State University, Virginia, USA
  • Master of Psychology (2004) - Virginia Polytechnic Institute and State University, Virginia, USA
  • Bachelor of Clinical Medicine (1998) - Hubei University of Medicine, Hubei, China

Professional Experience 💼

  • Adjunct Professor (2022-present) - Anhui Medical University, Hefei, China
  • Director (2021-present) - Brain Disorders and Neuromodulation Research Center, Anhui Mental Health Center, Hefei, China
  • Co-Principal Investigator (2018-2021) - Cognitive Neuropsychology Lab, University of Science and Technology of China, Hefei, China
  • Research Scientist (2014-2018) - School of Medicine, University of Missouri-Kansas City; Center for Behavioral Medicine/Department of Mental Health, Missouri, USA
  • Clinical Assistant Professor/Post-doc Fellow (2007-2013) - Department of Psychiatry and Behavioral Science, Texas A&M University and Central Texas Veterans Health Care System; Department of Psychology and Neuroscience, Baylor University, Texas, USA
  • Teaching/Research Assistant (2002-2006) - Department of Psychology, Virginia Tech, Virginia, USA

Fellowships & Honors 🏆

  • Anhui Province ‘Overseas High-level Talents’ Award (2019)
  • Fellowship, Athinoula A. Martinos Center for Biomedical Imaging, Harvard University (2010)
  • Travel Award, Graduate Student Association, Virginia Tech (2006)
  • Galper Fund Award, Department of Psychology, Virginia Tech (2005)
  • Multiple Travel Awards (2004-2006) - 1st, 2nd, and 3rd Joint ECNS and ISNIP Conferences
  • Graduate Research Development Project Grant, Virginia Tech (2003)

Affiliations & Memberships 🌐

  • Deputy Secretary - Sleep Branch, China Traditional Chinese Medicine Information Conference
  • Vice Director - Cognitive Behavioral Therapy Committee, Anhui Psychological Health Association
  • Member - World Psychiatric Association (WPA), Society for Psychophysiological Research (SPR), Cognitive Neuroscience Society (CNS)
  • Editorial Board Member - Brain Science Advances, Journal of Brain Research and Neurology, World Journal of Clinical Medicine Research, International Journal of Psychological and Brain Sciences, Advances in Health and Behavior
  • Reviewer - NeuroImage, Human Brain Mapping, Neural Regeneration Research, Psychophysiology, International Journal of Psychophysiology, Journal of Psychiatry Research, Psychiatry Research, and more

Journal Publications 📚

Dr. Li Wan has contributed significantly to the fields of psychology and neuroscience, with numerous publications in prestigious journals such as HeliyonHuman Brain MappingFrontiers in PsychologyLaboratory Medicine, and World Psychiatry. Her research covers a broad spectrum of topics, including affective disorders, brain morphology, cognitive neuropsychology, and the neural mechanisms underlying behavioral and psychiatric conditions.

Notable Publications 📑

"The neural mechanisms of immediate and follow-up of the treatment effect of hypnosis on smoking craving" 

  • Authors: Li, X., Chen, L., Ma, R., Rao, H., Zhang, X.
  • Journal: Brain Imaging and Behaviour
  • Year: 2020

"The Effect of Vocabulary Depth and Breadth on English Listening Comprehension Can Depend on How Comprehension Is Measured " 

  • Authors: Luo, Y., Song, H., Wan, L., Zhang, X.
  • Journal: Frontiers in Psychology
  • Year: 2021

"Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms "

  • Authors: Li, J., Wan, L., Feng, Y., Zhang, X., Xia, M
  • Journal: Lab Medicine
  • Year: 2021

"Brain morphology, harm avoidance, and the severity of excessive internet use"

  • Authors: Wan, L., Zha, R., Ren, J., Zuo, H., Zhang, X.
  • Journal: Human Brain Mapping
  • Year: 2022

"Decision tree distinguish affective disorder diagnosis from psychotic disorder diagnosis with clinical and lab factor"

  • Authors: Liu, X., Wang, X., Wen, C., Wan, L.
  • Journal: Heliyon
  • Year: 2022

Ali Mahmoud Ali Ahmed | Neurogenetics | Best Researcher Award

Dr. Ali Mahmoud Ali Ahmed | Neurogenetics | Best Researcher Award

The Royal Wolverhampton NHS Trust | United Kingdom

Author Profile

Scopus

Orcid ID

Google Scholar

Biography of Ali Mahmoud Ali Ahmed 🌟

Current Positions

  • Senior Clinical Fellow of Neurology (Jan 2024 - Present)
  • Neurology Specialist (MD Registrar) (June 2022 - Present)
    • Faculty of Medicine, Al-Azhar University 🌐
    • Al-Azhar University
    • Supervisor: Prof. Emad Fawzy, MD

Previous Positions

  • Neurology Specialist (Jan 2022 - Jan 2024)
  • Neurology Resident (MSc Registrar) (June 2019 - 2021)
    • Faculty of Medicine, Al-Azhar University
    • Supervisor: Prof. Mohamed Al-Bahay MG Reda, MD
  • House Officer (March 2018 - February 2019)
    • Al-Azhar University Hospitals

Clinical Experience 🩺

  • Neuro-genetics: Diagnosis and management of neurogenetic disorders.
  • Neuro-intensive care: Stroke unit management with extensive experience in critical cases.
  • Neuro-intervention: Performing diagnostic angiography and assisting in therapeutic procedures.
  • Neuroimmunology: Management of autoimmune CNS disorders.
  • Neurophysiology: Expertise in nerve conduction studies, EMG, and EEG.
  • Neuro-pediatrics: Management of neurological disorders in children.
  • Epilepsy: Treatment and management of epilepsy in adults and children.
  • Movement Disorders: Management of abnormal movements, including botulinum toxin injection.
  • Headaches: Treatment of various headache types.

Education 🎓

  • Medical Doctorate in Clinical Neurology (MD) (June 2022 - Present)
    • Faculty of Medicine, Al-Azhar University
  • Master of Clinical Neuro-Psychiatry (MSc) (June 2019 - 2022)
    • Faculty of Medicine, Al-Azhar University
  • Bachelor of Medicine and Bachelor of Surgery (MBBCh) (Oct 2011 - Dec 2017)
    • Faculty of Medicine, Al-Azhar University
    • Graduated among the top 10% with a GPA of 3.84

Honors, Awards, and Grants 🏅

  • 2017 IBRO-ISN School on Neurogenetics
  • 2nd Best Presentation on Mesenchymal Stem Cells (2014)
  • Award of Excellence in Histology (2013)
  • Al-Azhar Scholarship for Top Ten Students in the Republic (2011)

Language Skills 🌐

  • English
  • Arabic

Reviewer for Journals 📝

  • Medical Science Monitor
  • BMC Infectious Diseases
  • Tropical Medicine and Health (TMAH)
  • PLOS ONE

Research Instructor at Online Research Club 🧪

  • Primary projects on novel anti-hemozoin drugs and HBV gene mutations.
  • Conducted clinical trials and epidemiological studies.
  • Developed research methodologies and meta-analyses.

Teaching Experience 📚

  • Conducted numerous lectures and workshops on meta-analysis, medical statistics, and research methodologies.
  • Chief instructor for various research courses and diplomas.

Notable Publications

Prevalence and burden of dengue infection in Europe: A systematic review and meta-analysis

  • Authors: Ahmed, A.M., Mohammed, A.T., Vu, T.T., ... Hirayama, K., Huy, N.T.
  • Journal: Reviews in Medical Virology
  • Year: 2020

Association of Allergic Symptoms with Dengue Infection and Severity: A Systematic Review and Meta-analysis

  • Authors: Kien, N.D., El-Qushayri, A.E., Ahmed, A.M., ... Hirayama, K., Huy, N.T.
  • Journal: Virologica Sinica
  • Year: 2020

Erratum: Correction to: Association of Allergic Symptoms with Dengue Infection and Severity: A Systematic Review and Meta-analysis

  • Authors: Kien, N.D., El-Qushayri, A.E., Ahmed, A.M., ... Hirayama, K., Huy, N.T.
  • Journal: Virologica Sinica
  • Year: 2020

Factors associated with the success of trial without catheter in acute urinary retention due to benign prostatic hyperplasia

  • Authors: Phuong Hoai, D., Thang Tai, L., Huu Loc, T., ... Huy, N., Khanh, L.
  • Journal: Urological Science
  • Year: 2021

Outcomes of pregnancy in Egyptian women with multiple sclerosis in the new treatment era: a multi-center retrospective observational study

  • Authors: Ahmed, A.M., Reda, M.A.-B.M.G., Elsheshiny, A.H.
  • Journal: Egyptian Journal of Neurology, Psychiatry and Neurosurgery
  • Year: 2021

Kheireddine Ouali | Oxidative Stress and Diabetes | Best Researcher Award

Prof Kheireddine Ouali | Oxidative Stress and Diabetes | Best Researcher Award

University of Badji Mokhtar Annaba | Algeria

Author Profile

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Kheireddine Ouali was born on December 27, 1970, in Annaba, Algeria. He pursued his early education in his hometown before embarking on higher studies. His academic journey led him to specialize in biology and animal physiology, culminating in the attainment of a Doctorat d’État.

Professional Endeavors

Currently holding the prestigious position of Professor, Kheireddine Ouali serves as both an educator and a researcher. He is based at BP12 El Hadjar Annaba 23000, Algeria, and can be reached at 038562004 or via his mobile at 0561097708. His professional responsibilities extend to his role as the Director of the Laboratory of Environmental Biosurveillance, where he oversees significant research projects and initiatives.

Contributions and Research Focus on Oxidative stress and Diabetes

Ouali's research primarily focuses on biology and animal physiology. His contributions to these fields are substantial, with numerous publications and research projects that have advanced understanding and innovation. His work is particularly noted for its emphasis on environmental biosurveillance, addressing critical issues related to environmental health and safety.

Impact and Influence

Kheireddine Ouali has made a profound impact on the scientific community, both within Algeria and internationally. His research findings and academic contributions have influenced policies and practices in environmental health. Additionally, his role as an educator has enabled him to mentor and guide the next generation of scientists and researchers.

Academic Cites

Ouali's academic work has been widely cited in various scientific journals and publications. His research on animal physiology and environmental biosurveillance is frequently referenced by peers, underscoring his influence and the importance of his contributions to these fields.

Legacy and Future Contributions

As a leading figure in his field, Kheireddine Ouali's legacy is marked by his dedication to scientific advancement and education. His future contributions are anticipated to further enhance understanding in biology, animal physiology, and environmental health, ensuring that his impact will continue to be felt for years to come.

Notable Publications

Effect of subacute treatment with bisphenol A on oxidative stress biomarkers and lipid peroxidation in Gambusia affinis mosquitofish 2023(3)

Subchronic toxicity of iron-selenium nanoparticles on oxidative stress response, histopathological, and nuclear damage in amphibian larvae Rana saharica 2023(1)

Tempol a superoxide dismutase mimic reduces cardiac muscle cell death through the control of oxidative stress in streptozotocin-induced diabetes 2023(1)

Effect of contaminated diet with a plant growth regulator “1-methylcyclopropene” on the hematological parameters and liver function of albino Wistar rats 2023(1)

In Vivo and In Silico Studies Assessment of the Effects of Oral Exposure to 1-Methylcyclopropene on Liver Function in Male Albino Rats 2024

Bin Zhang | Gene Mutation | Best Researcher Award

Prof Bin Zhang | Gene Mutation | Best Researcher Award

Jining Medical University | China

AUTHOR PROFILE

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Bin Zhang's journey into the world of medical research began with a solid foundation in biomedical sciences. His early academic pursuits were marked by a dedication to understanding complex biological systems and a passion for contributing to the field of oncology. This academic dedication led him to become a young expert recognized under the prestigious Taishan Mount Scholars program in China.

PROFESSIONAL ENDEAVORS

In 2018, Bin Zhang was appointed as a researcher at the Affiliated Hospital of Jining Medical University. Here, he established the tumor metabolism research group, assuming the role of Principal Investigator. Under his leadership, the group has grown to focus on four key research directions: the regulatory mechanisms of tumor stem cells, the specificity of tumor biomacromolecules and energy metabolism, the regulation of energy metabolism by oncogenic gene mutations, and the screening of potential drugs targeting tumor metabolism.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE MUTATION

Bin Zhang's research has significantly advanced the understanding of tumor metabolism. His work has been published in esteemed journals such as Cell Reports Medicine, Biomaterials, Oncogene, Journal of Experimental & Clinical Cancer Research, and Stem Cells. These publications highlight his team's investigations into the intricate mechanisms of tumor biology and potential therapeutic targets. The research group delves into how tumor stem cells are regulated, how tumor biomacromolecules function, and how mutations in oncogenes affect energy metabolism, all of which are crucial for developing new cancer treatments.

IMPACT AND INFLUENCE

The impact of Bin Zhang's research is reflected in the high citation rate of his publications, with over 5000 citations to date and an H-Index of 34. His work has not only contributed valuable knowledge to the scientific community but has also influenced ongoing research and development in tumor metabolism. Furthermore, Bin Zhang has successfully secured ten patents, two of which have been transferred, demonstrating the practical applications and commercial potential of his research findings.

ACADEMIC CITES

Bin Zhang is also an active member of the academic community, serving as a reviewer for several high-impact journals including Stem Cells and Development, EBioMedicine, Stem Cell Research & Therapy, Molecular Carcinogenesis, and the Journal of Clinical Laboratory Medicine. His expertise is sought after in evaluating cutting-edge research and ensuring the quality of publications in these journals.

LEGACY AND FUTURE CONTRIBUTIONS

Bin Zhang's legacy in the field of tumor metabolism is marked by his innovative research and commitment to advancing cancer treatment. Currently, he is the principal investigator of two general projects funded by the National Natural Science Foundation of China, two projects funded by Shandong Province, and two projects funded by the Postdoctoral Foundation of China. His ongoing work promises to uncover new insights and develop novel therapies, continuing to push the boundaries of cancer research

NOTABLE PUBLICATIONS

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis 2023(7)

IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53 2023(4)

Therapeutic Efficacy of Mesenchymal Stem/Stromal Cell Small Extracellular Vesicles in Alleviating Arthritic Progression by Restoring Macrophage Balance 2023(1)

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines 2024

Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling 2024

Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Prof Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Cincinnati Children's Hospital Medical Center | United States

Author Profile

Scopus

Early Academic Pursuits

Qing Richard Lu embarked on his academic journey with a Bachelor of Science in Biochemistry from Peking Normal University in Beijing, China, which he completed in 1988. Following this, he pursued a Master of Science in Biophysics at Rutgers University, New Jersey, USA, completing his degree in 1993. He continued his studies at Rutgers University, earning a Ph.D. in Biochemistry in 1997 under the mentorship of Dr. Masayori Inouye.

Professional Endeavors

Dr. Lu's professional career began with a postdoctoral fellowship at the Dana-Farber Cancer Institute, Harvard Medical School, from 1997 to 2002. He worked with Dr. Chuck D. Stiles and collaborated with Dr. David Rowitch. In 2002, he joined the UT Southwestern Medical Center as an Assistant Professor in the Department of Developmental Biology, where he held the position of Southwestern Medical Foundation Endowed Scholar in Medical Research. He was promoted to Associate Professor with tenure in 2009 and continued in this role until 2013. In 2013, Dr. Lu joined Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine. He currently holds the position of Professor with tenure in the Department of Pediatrics. Additionally, he serves as the Scientific Director of the Brain Tumor Center and Program Leader of the Brain Tumor Program in the Division of Experimental Hematology and Cancer Biology, Cancer & Blood Diseases Institute.

Contributions and Research Focus on Neurodegenerative Diseases

Dr. Lu's research primarily focuses on the molecular and cellular mechanisms underlying brain tumors. His work is significant in understanding the biology of brain cancer and developing new therapeutic strategies. He has made notable contributions to the field of experimental hematology and cancer biology through his research on brain tumor development, progression, and treatment.

Impact and Influence

Throughout his career, Dr. Lu has influenced the field of pediatric oncology and neurobiology. His research has provided insights into the genetic and biochemical pathways involved in brain tumors, contributing to the development of novel therapeutic approaches. His work has been recognized through various academic appointments and endowed scholarships, reflecting his significant impact on medical research.

Academic Cites

Dr. Lu's work has been widely published in numerous scientific journals, and his research findings are frequently cited by peers in the field. His publications contribute to the broader scientific understanding of brain tumors and their treatment, solidifying his reputation as a leading expert in the field.

Legacy and Future Contributions

As a leading figure in pediatric oncology and neurobiology, Dr. Lu's legacy is marked by his commitment to advancing scientific knowledge and improving patient outcomes. His ongoing research efforts and leadership roles at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine continue to shape the future of brain tumor research and treatment. Dr. Lu’s future contributions are expected to further enhance the understanding and management of brain tumors, paving the way for innovative therapeutic solutions and improved patient care.

Notable Publications 

Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Prof Dr. Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Nanjing Medical University | China

AUTHOR PROFILE

Scopus

orcid ID

EARLY ACADEMIC PURSUITS

Wei Wu began his academic journey at Nanjing Medical University, where he earned a Bachelor of Science in Preventive Medicine in 2007. He continued his studies at the same institution, obtaining a Ph.D. in Toxicology in 2012. His doctoral research was conducted in the Department of Toxicology, focusing on toxicological mechanisms and their implications for public health. Following his Ph.D., Wu completed a postdoctoral fellowship in Reproductive and Developmental Toxicology at the State Key Laboratory of Reproductive Medicine, also at Nanjing Medical University. In 2017-2018, he broadened his research horizons as a guest researcher at the National Institute of Environmental Health Sciences in the United States, specializing in Epidemiology.

PROFESSIONAL ENDEAVORS

Wei Wu's professional career is anchored at Nanjing Medical University, where he has ascended from a research assistant to a professor. His roles include:

  • 2022-present: Professor, Department of Toxicology, School of Public Health
  • 2022-present: Assistant Dean, School of Public Health
  • 2022-present: Secretary General, Jiangsu Society of Toxicology
  • 2021-present: Associate Department Chair, Department of Scientific Research Sharing Platform (Core Facility)
  • 2018-present: Associate Department Chair, Department of Toxicology
  • 2016-2022: Associate Professor, Department of Toxicology
  • 2012-2016: Lecturer, Department of Toxicology
  • 2010-2012: Research Assistant, School of Public Health

CONTRIBUTIONS AND RESEARCH FOCUS ON DNA METHYLATION AND MALE REPRODUCTIVE HEALTH

Wei Wu has made significant contributions to the field of toxicology, particularly in reproductive and developmental toxicology. His research has focused on the toxicological effects of environmental and chemical exposures on reproductive health. His work also delves into the molecular mechanisms underlying these toxicological impacts, aiming to develop preventive strategies and therapeutic interventions.

IMPACT AND INFLUENCE

Wei Wu has received numerous honors and awards that reflect his impact and influence in the field of toxicology. Notable accolades include:

  • 2023: "Good Youth Around Us" by the Communist Youth League Jiangsu Provincial Committee
  • 2022: Friendship Teaching Award of Nanjing Medical University
  • 2020: Ministry of Education Fok Ying Tung Young Teachers' Award
  • 2019: Clarivate Publons Peer Review Awards (top 1% reviewers in Crossfield and Clinical Medicine)
  • 2018: Publons Peer Review Awards (top 1% reviewers in Clinical Medicine)
  • 2017: Multiple awards for excellent papers and teaching achievements

ACADEMIC CITATIONS

Wei Wu holds various editorial positions, contributing to the dissemination of scientific knowledge in toxicology and related fields. He serves on the editorial boards of several prestigious journals, including:

  • Scientific Reports
  • SM Journal of Environmental Toxicology
  • Global Journal of Genitourinary Cancer
  • Austin Journal of Reproductive Medicine & Infertility
  • Journal of Clinical Obstetrics, Gynecology & Infertility
  • Medicine
  • Frontiers in Endocrinology
  • Frontiers in Physiology

As an editor-in-chief, he leads the International Journal of Sexual Health and Reproductive Health Care and the Research International Journal of Endocrinology and Diabetes.

LEGACY AND FUTURE CONTRIBUTIONS

Wei Wu’s ongoing research and professional activities suggest a lasting legacy in the field of toxicology. His leadership roles within professional societies, such as the Jiangsu Society of Toxicology and the Jiangsu Provincial Preventive Medical Association, underline his influence in shaping future research directions and policies. His dedication to teaching and mentoring the next generation of toxicologists ensures that his impact will continue to resonate in the academic and scientific communities.

NOTABLE PUBLICATIONS

Cohort Profile: The Jiangsu Birth Cohort 2023(3)

Effect of prenatal perfluoroheptanoic acid exposure on spermatogenesis in offspring mice 2023(4)

Adverse effect of assisted reproductive technology-related hyperoestrogensim on the secretion and absorption of uterine fluid in superovulating mice during the peri-implantation period 2023(2)

Association between prenatal perfluorinated compounds exposure and risk of pregnancy complications: A meta-analysis 2024

Effect of prenatal exposure to phthalates on birth weight of offspring: A meta-analysis 2024

Sara Salvador | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Dr. Sara Salvador | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Gregorio Maranon University Hospital | Spain

Author Profile

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Since 2017, I have been dedicated to advancing the field of pharmacogenetics, beginning as a research assistant and progressing through to postdoctoral researcher at the Pharmacogenetics Laboratory of the Gregorio Marañón General University Hospital. My journey started with foundational research roles and evolved into leadership positions within various pharmacogenomic studies.

PROFESSIONAL ENDEAVORS

Starting as a research assistant, I gradually transitioned to roles as a predoctoral and postdoctoral researcher, accumulating invaluable experience and expertise in pharmacogenetics. My work has been primarily focused on pharmacogenomic studies in diverse medical areas such as colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENMICS AND PERSONALIZED MEDICINE

Throughout my career, I have actively contributed to 21 publications in pharmacogenomics, with a particular emphasis on colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases. Of these publications, I served as the first author for 14, showcasing my significant contributions to the field. Notably, my doctoral thesis in 2020 centered on intestinal inflammatory disease, underscoring my commitment to advancing knowledge in this area.

IMPACT AND INFLUENCE

My contributions have not gone unnoticed, as evidenced by receiving the AEFA (Spanish Clinical Laboratory Association) award for quality and innovation in 2019. Additionally, my research has been recognized through presentations at 20 national and international conferences, including 5 oral communications. I have been honored with the best oral communication award at three conferences, highlighting the impact of my work.

ACADEMIC CITES

My research has contributed to the academic discourse, with citations in various publications, further validating the significance and influence of my work in pharmacogenetics awards and related fields.

LEGACY AND FUTURE CONTRIBUTIONS

As an active member of the Spanish Society of Pharmacogenetics awards and the Spanish Association of Human Genetics, I continue to contribute to the advancement and dissemination of knowledge in these critical areas of public health. My ongoing commitment to research and collaboration ensures that my contributions will continue to shape the future of pharmacogenetics.

NOTABLE PUBLICATIONS

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children 2023(3)

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease 2023(7)

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort 2023(7)

Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain 2022(5)

Pharmacogenetics to avoid adverse reactions in cardiology: Ready for implementation? 2021(4)

Ebru Dundar-Yenilmez | Neurogenetics and Neuropsychiatric Disorders | Best Researcher Award

Prof Dr. Ebru Dundar-Yenilmez | Neurogenetics and Neuropsychiatric Disorders | Best Researcher Award

Cukurova University | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Ebru Dündar Yenilmez began her academic journey with a Bachelor's degree in Biology from Çukurova University's Faculty of Science and Literature. This foundational education laid the groundwork for her future pursuits in biochemistry and genetics. She continued her studies at the same university, undertaking a Master's degree followed by a PhD in Biochemistry from the Institute of Health Science. These early academic pursuits provided her with a comprehensive understanding of biological systems, paving the way for her specialization in molecular biochemistry, epigenetics, and pharmacogenetics.

PROFESSIONAL ENDEAVORS

Following the completion of her PhD, Ebru Dündar Yenilmez embarked on a career as a research assistant at Çukurova University's Faculty of Medicine, Department of Medical Biochemistry. Over the years, she demonstrated excellence in research and teaching, leading to her appointment as a lecturer upon obtaining her doctorate. Her dedication to academia and her field is evident in her commitment to teaching medical biochemistry at both the Medicine and Dentistry faculties.

CONTRIBUTIONS AND RESEARCH FOCUS ON NEUROGENETICS AND NEUROPSYCHIATRIC DISORDERS

Ebru Dündar Yenilmez has made significant contributions to the fields of molecular biochemistry, epigenetics, pharmacogenetics, and molecular diagnostics techniques. Her research endeavors have focused on understanding the molecular basis of hereditary diseases, with a particular emphasis on the role of DNA and RNA in disease pathogenesis. Through her work, she has advanced our understanding of complex biological processes and paved the way for the development of novel diagnostic and therapeutic approaches.

IMPACT AND INFLUENCE

As a member of esteemed organizations such as the European Society of Human Genetics, Turkish Society of Biochemistry, and European Society Pharmacogenomics and Personalized Therapy, Ebru Dündar Yenilmez has actively contributed to the global scientific community. Her research findings have been disseminated through publications in prestigious journals and presentations at international conferences, amplifying her impact and influence within her field.

ACADEMIC CITATIONS

Ebru Dündar Yenilmez's contributions to academia are reflected in her citation record, with her research being cited by peers and scholars across the globe. Her work serves as a cornerstone for further research and exploration in molecular biochemistry and related disciplines, further solidifying her position as a respected authority in her field.

LEGACY AND FUTURE CONTRIBUTIONS

Ebru Dündar Yenilmez's legacy extends beyond her individual accomplishments, encompassing the students she has mentored and the knowledge she has imparted. As she continues her academic journey, she remains dedicated to pushing the boundaries of scientific understanding and fostering the next generation of researchers. Her future contributions hold the promise of further unraveling the complexities of molecular biology and advancing personalized medicine for the benefit of society.

NOTABLE PUBLICATIONS

Cord Blood Hematological Parameters of Fetuses Detected Different Thalassemia Genotypes in the Second Trimester of Pregnancy 2023 (2)

The effect of Vitamin D on testosterone and uncarboxylated osteocalcin levels in aged male rats 2022

Investigation of beta globin gene mutations in Syrian refugee patients with thalassemia major 2019(2)

Beneficial effects of rolipram, a phosphodiesterase 4 specific inhibitor, on testicular torsion-detorsion injury in rats 2018(16)

A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women 2018(11)

 

Zakaria Jellil | Optoelectronic Applications | Best Researcher Award

Mr. Zakaria Jellil | Optoelectronic Applications | Best Researcher Award

Mohammed V University in Rabat | Morocco

Author Profile 

Scopus

EARLY ACADEMIC PURSUITS

Zakaria Jellil embarked on his academic journey with a strong foundation in the sciences. His early academic pursuits include earning a Baccalauréat in Physics-Chemistry from lycée Mohamed VI Guelmim in 2012, showcasing his commitment to the field from the outset.

PROFESSIONAL ENDEAVORS

Building upon his solid academic background, Jellil achieved a Bachelor's degree in Fundamental Physics from the University Ibn Zohr, Agadir, Morocco, in 2015. Subsequently, he pursued a Master's degree in Nuclear Physics and Radiation Technology at the University Mohamed V, Rabat, Morocco, completing his studies in the academic year 2017/2018.

CONTRIBUTIONS AND RESEARCH FOCUS ON OPTOELECTRONIC APPLICATIONS 

Jellil's dedication to the field of Physics continued with his enrollment in the Doctoral program in Condensed Matter Physics at the University Mohamed V, Rabat, Morocco. Currently in his second year since 2022, his research focus revolves around the intricate aspects of condensed matter, showcasing his commitment to advancing scientific knowledge in this specialized domain.

IMPACT AND INFLUENCE

In 2019-2021, Jellil further honed his expertise by undertaking training at the Center for Aggregation Training in Casablanca, Morocco, leading to his accreditation as an Aggregated Professor in Physics-Chemistry. This accomplishment not only solidified his academic standing but also positioned him as a key influencer and educator in the field.

ACADEMIC CITES

Jellil's academic journey also includes obtaining a significant milestone in the form of an Aggregated Professorship in Physics-Chemistry, conferred by the Ministry of National Education, Morocco, in 2021.

LEGACY AND FUTURE CONTRIBUTIONS

As he progresses through his doctoral studies, Zakaria Jellil is poised to leave a lasting legacy in the realm of Physics. His dedication, from early academic pursuits to current research endeavors, highlights a promising future where his contributions are anticipated to shape and elevate the scientific landscape.

Notable Puclications

Pressure-induced band gap engineering and enhanced optoelectronic properties of non-toxic Ca-based perovskite CsCaCl3: Insights from density functional theory

Analysis of the structural, electronic, optical and mechanical properties of CsGeI2Br under tensile and compressive strain for optoelectronic applications: A DFT computational perspective